First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients

First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients

Enfortumab vedotin (EV), an antibody-drug conjugate directed against Nectin-4, significantly prolonged survival compared to standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who previously received platinum-based chemotherapy and a PD-1 or PD-L1 inhibitor. Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Christof Vulsteke (Author), Laurens De Cocker (Author), Alfonso Gómez de Liaño (Author), Cristina Montesdeoca (Author), Astrid De Meulenaere (Author), Lieselot Croes (Author), Danielle Delombaerde (Author), Bernadett Szabados (Author), Thomas Powles (Author)
Format: Book
Published: MDPI AG, 2023-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items